Reconstructing the course of the COVID-19 epidemic over 2020 for US states and counties: Results of a Bayesian evidence synthesis model

Author:

Chitwood Melanie H.ORCID,Russi MarcusORCID,Gunasekera KennethORCID,Havumaki JoshuaORCID,Klaassen FayetteORCID,Pitzer Virginia E.ORCID,Salomon Joshua A.,Swartwood Nicole A.ORCID,Warren Joshua L.,Weinberger Daniel M.ORCID,Cohen Ted,Menzies Nicolas A.ORCID

Abstract

Reported COVID-19 cases and deaths provide a delayed and incomplete picture of SARS-CoV-2 infections in the United States (US). Accurate estimates of both the timing and magnitude of infections are needed to characterize viral transmission dynamics and better understand COVID-19 disease burden. We estimated time trends in SARS-CoV-2 transmission and other COVID-19 outcomes for every county in the US, from the first reported COVID-19 case in January 13, 2020 through January 1, 2021. To do so we employed a Bayesian modeling approach that explicitly accounts for reporting delays and variation in case ascertainment, and generates daily estimates of incident SARS-CoV-2 infections on the basis of reported COVID-19 cases and deaths. The model is freely available as the covidestim R package. Nationally, we estimated there had been 49 million symptomatic COVID-19 cases and 404,214 COVID-19 deaths by the end of 2020, and that 28% of the US population had been infected. There was county-level variability in the timing and magnitude of incidence, with local epidemiological trends differing substantially from state or regional averages, leading to large differences in the estimated proportion of the population infected by the end of 2020. Our estimates of true COVID-19 related deaths are consistent with independent estimates of excess mortality, and our estimated trends in cumulative incidence of SARS-CoV-2 infection are consistent with trends in seroprevalence estimates from available antibody testing studies. Reconstructing the underlying incidence of SARS-CoV-2 infections across US counties allows for a more granular understanding of disease trends and the potential impact of epidemiological drivers.

Funder

National Institute of General Medical Sciences

fogarty international center

national institute of allergy and infectious diseases

centers for disease control and prevention

national institute on drug abuse

Publisher

Public Library of Science (PLoS)

Subject

Computational Theory and Mathematics,Cellular and Molecular Neuroscience,Genetics,Molecular Biology,Ecology,Modeling and Simulation,Ecology, Evolution, Behavior and Systematics

Reference43 articles.

1. Coronavirus in the U.S.: Latest Map and Case Count. Retrieved from https://www.nytimes.com/interactive/2020/us/coronavirus-us-cases.html

2. Coronavirus. Retrieved from https://www.washingtonpost.com/graphics/2020/national/coronavirus-us-cases-deaths/?itid=hp_pandemic%20test

3. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review;DP Oran;Annals of internal medicine,2020

4. The Usefulness Of SARS-CoV-2 Test-Positive Proportion As A Surveillance Tool;MDT Hitchings;American Journal of Epidemiology,2021

5. The impact of changes in diagnostic testing practices on estimates of COVID-19 transmission in the United States;VE Pitzer;American Journal of Epidemiology,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3